Atomistry » Bromine » PDB 3ok5-3r1e » 3p0m
Atomistry »
  Bromine »
    PDB 3ok5-3r1e »
      3p0m »

Bromine in PDB 3p0m: Human Camp-Dependent Protein Kinase in Complex with An Inhibitor

Enzymatic activity of Human Camp-Dependent Protein Kinase in Complex with An Inhibitor

All present enzymatic activity of Human Camp-Dependent Protein Kinase in Complex with An Inhibitor:
2.7.11.11;

Protein crystallography data

The structure of Human Camp-Dependent Protein Kinase in Complex with An Inhibitor, PDB code: 3p0m was solved by H.Koester, A.Heine, G.Klebe, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 21.47 / 2.03
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 71.890, 76.530, 79.480, 90.00, 90.00, 90.00
R / Rfree (%) 16.9 / 20.5

Bromine Binding Sites:

The binding sites of Bromine atom in the Human Camp-Dependent Protein Kinase in Complex with An Inhibitor (pdb code 3p0m). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Human Camp-Dependent Protein Kinase in Complex with An Inhibitor, PDB code: 3p0m:

Bromine binding site 1 out of 1 in 3p0m

Go back to Bromine Binding Sites List in 3p0m
Bromine binding site 1 out of 1 in the Human Camp-Dependent Protein Kinase in Complex with An Inhibitor


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Human Camp-Dependent Protein Kinase in Complex with An Inhibitor within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br351

b:28.2
occ:0.77
BR A:4SB351 0.0 28.2 0.8
C09 A:4SB351 1.9 26.3 1.0
C10 A:4SB351 2.8 27.1 1.0
C08 A:4SB351 2.8 23.6 1.0
O A:4SB351 3.0 21.9 1.0
CZ A:PHE327 3.3 21.8 1.0
O A:VAL123 3.5 25.0 1.0
CE1 A:PHE327 3.5 20.6 1.0
CD2 A:LEU173 3.5 14.9 0.3
CD1 A:TYR122 3.8 21.3 1.0
N A:VAL123 3.8 23.3 1.0
CD1 A:LEU49 3.9 18.1 1.0
CD1 A:LEU173 3.9 14.7 0.7
CE1 A:TYR122 4.0 23.5 1.0
C01 A:4SB351 4.1 29.1 1.0
C07 A:4SB351 4.2 25.6 1.0
C A:VAL123 4.2 27.5 1.0
CG A:LEU173 4.3 17.9 0.3
CG A:LEU173 4.3 19.0 0.7
CE2 A:PHE327 4.4 22.8 1.0
CA A:VAL123 4.4 22.6 1.0
CB A:VAL123 4.4 23.6 1.0
CB A:ALA70 4.5 18.8 1.0
C06 A:4SB351 4.7 22.8 1.0
CD1 A:PHE327 4.7 19.4 1.0
C A:TYR122 4.9 21.3 1.0
CA A:TYR122 4.9 17.2 1.0
CG A:LEU49 4.9 22.1 1.0
CB A:LEU49 5.0 21.3 1.0

Reference:

H.Koester, T.Craan, S.Brass, A.Heine, G.Klebe. Fragment Based Drug Design on Pka To Be Published.
Page generated: Sat Dec 12 02:14:32 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy